[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"smoking-behavior\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:smoking-behavior":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,43,72],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100602129","a-novel-dialectical-behavior-therapy-brief-group-intervention-for-cigarette-smoking-by-patients-with-cancer-an-open-clinical-trial-100602129",false,"NCT07119489","A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial","Inclusion Criteria:\n\n1. Smoke ≥1 cigarettes every day in the past 30 days per participant report.\n2. Smoked at least 100 cigarettes (5 packs) in lifetime.\n3. Confirmation of cancer diagnosis at any time.\n4. Patient encounter with an AHWFBCCC provider within the last two years.\n5. Age ≥ 18 years at the time of consent.\n6. Ability to understand and willingness to sign an IRB-approved informed consent, in English, directly.\n7. Able and willing to participate in video conference.\n\nExclusion Criteria:\n\n1. Patients actively receiving external tobacco use counseling or using tobacco cessation medications.\n2. Prior experience with more than five sessions of DBT-ST.\n3. Medical or psychiatric conditions limiting compliance with study requirements including suspected or reported cognitive impairment.\n4. Self-reported use of any psychoactive substance \\[except marijuana and nicotine\\] within the last 30 days.\n5. Have active and severe suicidal ideation at time of eligibility assessment or suicide attempt within the past month.","ALL","18 Years",{"count":18,"type":19},16,"ESTIMATED","INTERVENTIONAL",[22],"NA","The purpose of this research study is to learn more about how Dialectical Behavior Therapy - Skills Training can help patients with cancer who smoke cigarettes cut down on or stop their smoking.",[25],"Smoking Behavior",[27,28,29],"Dialectical Behavior Therapy","Cancer","Smoking","RECRUITING","2026-05-21",{"date":33,"type":34},"2026-05-26","ACTUAL",{"date":36,"type":34},"2026-02-11",{"date":38,"type":19},"2026-11",{"name":40,"class":41},"Wake Forest University Health Sciences","OTHER",2,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":50,"sex":15,"minAge":51,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":20,"phases":54,"briefSummary":55,"conditions":56,"keywords":59,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":42},"100576641","communicating-about-nicotine-reduction-in-cigarettes-100576641","NCT06787937","Communicating About Nicotine Reduction in Cigarettes","Communicating About Nicotine and Differential Risks of Tobacco Products in Priority Populations","Inclusion Criteria:\n\n* Age 21+ years\n* Current smoker (self-report as having smoked 100 cigarettes in their lifetime and currently smoking on 27+ days out of past 30, expired breath carbon monoxide \\[CO\\] ≥6ppm to assess regular smoking)\n* Can speak, read, and write in English\n* Available for period of study\n* Willing to try novel research cigarettes\n\nExclusion Criteria:\n\n* Pregnancy or lactation\n* Member of the same household as a study subject\n* Unwilling to use research cigarettes as part of the trial",true,"21 Years",{"count":53,"type":19},1230,[22],"The goal of this clinical trial is to learn how a messaging campaign about reduced nicotine cigarettes and policy, combined with the use of very low nicotine cigarettes (VLNCs), affects smoking behavior and attitudes among adult smokers. The study also aims to assess the efficacy of the messages in different populations, including smokers with past-month serious psychological distress (SPD), low socioeconomic status (SES), and those in neither category.\n\nThe primary hypothesis is: exposure to messages in combination with VLNC use will lead to less cigarettes use compared to VLNCs without messages.\n\nResearchers will compare: The effects of receiving VLNCs with messages (treatment group) to receiving VLNCs without messages (control group).\n\nParticipants will: Complete a baseline survey and be randomly assigned to one of two groups: treatment (VLNCs + messages) or control (VLNCs only). Attend weekly study visits for surveys, breath samples, and receive supply of VLNCs , either with or without the messaging campaign. Complete brief daily surveys through text messages.",[57,25,58],"Tobacco Products","Cigarette Use",[60,61,62],"smoking","health communication","very low nicotine cigarettes","2025-10-28",{"date":65,"type":34},"2025-10-29",{"date":67,"type":34},"2025-09-11",{"date":69,"type":19},"2029-01-31",{"name":71,"class":41},"Georgia State University",{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":76,"acronym":4,"eligibilityCriteria":77,"healthyVolunteers":11,"sex":78,"minAge":16,"maxAge":4,"enrollmentInfo":79,"targetDuration":4,"studyType":81,"phases":4,"briefSummary":82,"conditions":83,"keywords":93,"overallStatus":97,"whyStopped":4,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":107},"100570688","histological-results-in-transgender-individuals-assigned-to-females-at-birth-undergoing-gender-affirmation-surgery-and-in-testosterone-therapy-100570688","NCT06710496","HISTOLOGICAL RESULTS IN TRANSGENDER INDIVIDUALS ASSIGNED TO FEMALES AT BIRTH UNDERGOING GENDER AFFIRMATION SURGERY AND IN TESTOSTERONE THERAPY","Inclusion Criteria:\n\n* gender incongruence diagnosis\n* people assigned female at birth\n* age \\>18 years\n* gender affirming surgery with hysterectomy\n* testosterone therapy\n\nExclusion Criteria:\n\n* previous gynecological surgery\n* previous gynecological disorder diagnosis","FEMALE",{"count":80,"type":19},100,"OBSERVATIONAL","The aim of this study is to report histological results of genital organs removed during gender affirmg surgery in transgender people assigned female at birth (AFAB), to increase the knowledge about the long-term effects of gender affirming hormone therapy with testosterone on these organs and to evaluate the incidence of benign and malign gynecological pathology in AFAB transgender people.",[84,25,85,86,87,88,89,90,91,92],"Pregnancy","Testosterone Replacement Therapy","Drugs","Comorbidities and Coexisting Conditions","Gynecological Surgery","Transgender Men","Gender Affirmation Surgery","Hormone Replacement Therapy","Gynecological Disorders",[94,95,96],"transgender","afab","histology","NOT_YET_RECRUITING","2024-11-26",{"date":100,"type":34},"2024-11-29",{"date":102,"type":19},"2024-12",{"date":104,"type":19},"2025-12",{"name":106,"class":41},"IRCCS Azienda Ospedaliero-Universitaria di Bologna",1]